A biomarker test to measure progression for Parkinson's Disease is available in the US before 2029
5
14
Ṁ143Ṁ110
2029
85%
chance
1D
1W
1M
ALL
There will be a test of a biomarker which meaningfully correlates with parkinson's progression for at least a signficant subset (>10% of those diagnosed clinically) of people with Parkinson's disease in the US before 2029
examples: Patient has classic non-genetic PD from a clinical diagnosis based on symptoms (rigidity, etc.). There will be a test which they can take which shows the severity of the disease, and which when given repeatedly can be used to measure how much or less the disease has progressed
Get Ṁ200 play money
More related questions
Related questions
A Nobel prize in medicine award statement mentions Parkinson's disease before 2037
54% chance
Will the FDA approve a disease-modifying treatment for Parkinson's disease by 2025?
16% chance
Biological test for early detection of Parkinson's Disease by 2028
82% chance
Will Parkinson's be curable by 2028
6% chance
Will Bing diagnose Parkinson's disease in California on May 1 2035?
79% chance
Will AI be regularly used to diagnose complex diseases by 2028?
35% chance
The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
20% chance
Will Bing diagnose Parkinson's disease in EU on May 1 2026?
58% chance